Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
Thomas W. Geisbert(The University of Texas Medical Branch at Galveston), Nancy J. Sullivan(National Institute of Allergy and Infectious Diseases), Clement Asiedu(National Institutes of Health), Richard A. Koup(Aaron Diamond AIDS Research Center), Jenny Hendriks(Janssen (Netherlands)), Peter B. Jahrling(National Institutes of Health), Joshua C. Johnson(National Institutes of Health), Jort Vellinga(Johnson & Johnson (Netherlands)), Lisa E. Hensley(National Center for Emerging and Zoonotic Infectious Diseases), Maria Grazia Pau, Sabué Mulangu(National Institutes of Health), Jerome Custers(Johnson & Johnson (Netherlands)), Mario Roederer(National Institutes of Health), Daphne A. Stanley(National Institutes of Health), Joan B. Geisbert(The University of Texas Medical Branch at Galveston), Michael Bailey(General Department of Preventive Medicine), Jaap Goudsmit(Harvard University), Anna N. Honko
Cited by 225
Related Papers
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
T-cell quality in memory and protection: implications for vaccine design
|Nature reviews. Immunology|2008|1.6k
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
|Nature Medicine|2007|1.4k